Companies: 10,795·Total market cap: $144.5T
Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

CRNXNASDAQHealthcare● Active
$33.60
+$0.68(+2.06%)
Market Cap$3.5B
P/E Ratio—
52W High$57.99
52W Low$25.83
ForecastMarket CapPE Ratio

Crinetics Pharmaceuticals, Inc.（CRNX）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

crnx · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 18 位华尔街分析师

SellBuy

Buy

18 位分析师

共识

评级分布

Strong Buy
0
Buy
18
Hold
0
Sell
0
Strong Sell
0
合计: 18 · 买入占比: 100.0%

12 个月目标价

High

$105

Consensus

$85.83

+160.7% upside

Low

$67.00

Median: $85.5 · Last Close: $32.92

Crinetics Pharmaceuticals, Inc.（CRNX）的分析师共识为 Buy，基于过去 3 个月内 18 位华尔街分析师的评级。CRNX 的 12 个月平均目标价为 $85.83，相对当前价 $32.92 代表 +160.7% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $86 (160.7%)

Consensus Target

$85.83

160.7% upside

High Target

$105

219.0%

Low Target

$67

103.5%

Current Price

$32.92

as of today

Based on analyst price targets, the CRNX stock price prediction for the next 12 months ranges from $67 to $105. The consensus CRNX price forecast of $85.83 implies 160.7% upside from the current price of $32.92.

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$31.53↓ 4.23%

1-day model range: $31.31–$31.75. Peak: $31.75 (-4.23%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$35+5.7%
2028$36+9.3%
2029$37+11.5%
2030$37+12.9%
2031—+13.7%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)34.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CRNX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$33.55SELL
MA 10$34.97SELL
MA 20$35.81SELL
MA 50$37.58SELL
MA 100$41.07SELL
MA 200$41.55SELL
Current $CRNX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$33.83SELL
EMA 10$34.62SELL
EMA 20$35.73SELL
EMA 50$37.55SELL
EMA 100$39.33SELL
EMA 200$40.08SELL
Current $CRNX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Evercore ISI Group2026-05-15
Maintains
Outperform→Outperform
Oppenheimer2026-05-11
Maintains
Outperform→Outperform
Citizens2026-05-08
Maintains
Market Outperform→Market Outperform
Citizens2026-04-28
Maintains
Market Outperform→Market Outperform
Citizens2026-03-02
Maintains
Market Outperform→Market Outperform
Goldman Sachs2026-01-12
Upgrade ↑
Neutral→Buy
Citizens2026-01-08
Maintains
Market Outperform→Market Outperform
Morgan Stanley2026-01-06
Maintains
Overweight→Overweight
Citizens2025-11-07
Maintains
Market Outperform→Market Outperform
Oppenheimer2025-09-30
Maintains
Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Crinetics Pharmaceuticals, Inc. (CRNX) stock. Of the recent 80 rating actions, 3 were upgrades and 0 were downgrades. 18 analysts currently cover CRNX.

分析师推荐趋势

Buy ratings6 → 3↓ 3
Hold ratings1 → 0↓ 1
Sell ratings0 → 0

CRNX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 3 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$69M

↓ 83.7% YoY

Revenue Next Year

$173M

↑ 152.4% YoY

EPS This Year

$-4.80

EPS Next Year

$-4.21

↓ 12.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CRNX EPS of $-4.80 for the current fiscal year, based on estimates from 10 analysts. The CRNX revenue forecast is $69M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CRNX 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRNX 的共识目标价为 $85.83（+160.7% 上行空间），分析师共识为 Buy。

CRNX 的短期预测（明日）为 $31.53（-4.23%）。 CRNX 对 2027 年的股价预测均值为 $35。 CRNX 对 2030 年的预测区间为 $34–$40。

Crinetics Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 CRNX。CRNX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

CRNX 预测 · 8 个问题

根据 18 位华尔街分析师，CRNX 的 12 个月平均目标价为 $85.83，最高 $105.00、最低 $67.00。若有图表，中位目标价可在上方查看。相对当前价 $32.92，隐含约 +160.7% 的上行空间。

CRNX 目标价CRNX 分析师目标价CRNX 12个月目标价目标价 CRNX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.